Paulina Trendelenburg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Paulina Trendelenburg

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Therapeutic Advances in Neurological Disorders|February 19, 2024

Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosisSimon Faissner, Marielena Bongert, Paulina Trendelenburg, et al.

Frontiers in Immunology|September 19, 2022

Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccinationSimon Faissner, Neele Heitmann, Carlos Plaza-Sirvent, et al.

Brain Communications|December 5, 2025

Eomesodermin-expressing CD4 Th cells and association with multiple sclerosis progression and brain atrophyMarielena Bongert, Emelie Schönauer, Paulina Trendelenburg, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Therapeutic Advances in Neurological Disorders|February 19, 2024

Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosisSimon Faissner, Marielena Bongert, Paulina Trendelenburg, et al.

Frontiers in Immunology|September 19, 2022

Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccinationSimon Faissner, Neele Heitmann, Carlos Plaza-Sirvent, et al.

Brain Communications|December 5, 2025

Eomesodermin-expressing CD4 Th cells and association with multiple sclerosis progression and brain atrophyMarielena Bongert, Emelie Schönauer, Paulina Trendelenburg, et al.

Pageof 1